PropertyValue
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/ns/prov#value
  • VEGF as the critical cytokine in tumour neoangiogenesis could be therapeutically blocked by inhibitors such as anti-VEGF-antibodies or anti-VEGF-receptor-antibodies or other therapeutic agents.
http://www.w3.org/ns/prov#wasQuotedFrom
  • nih.gov